EVOTEC SE INH O.N.
Commented by Carsten Mainitz on January 20th, 2022 | 12:14 CET
Evotec, Defence Therapeutics, Formycon - Who will benefit from Omicron?
The Coronavirus has shown that without biotechnology and ongoing research, we are relatively defenseless against the whims of nature. What would have happened if novel technology had not been available to produce potent vaccines in a very short time? Would our intensive care units have been as crowded as they were in Italy at the beginning of the pandemic? Would hospital triage be the norm today? No one can say for sure, but history has shown how epidemics - such as the Spanish flu - have claimed many lives in the past.
Read
Commented by Carsten Mainitz on August 16th, 2021 | 11:20 CEST
Defence Therapeutics, Moderna, Evotec - Bet on the front-runners!
Health is our most important asset. Biotech companies that protect it save not only human lives but also reap high profits. The price development of many biotech stocks over the past few months has been breathtaking. Investors are advised to focus on the frontrunners, as the market position gained as a first mover, the leadership position in a niche or innovative solution, will enable the companies to keep their competitors at bay for a long time to come.
Read
Commented by Stefan Feulner on August 12th, 2021 | 13:42 CEST
ThyssenKrupp, Triumph Gold, Evotec - Growth before inflation
After the disastrous Corona year 2020 filled with profit slumps, the economy is coming back to life. The quarterly figures currently being reported indicate rising returns once again and thus an end to the dry spell. However, the inflation rate is also rising enormously; in Germany, it jumped to its highest level in almost 30 years, according to the Federal Statistical Office. Growth and job creation take precedence over price stability - a dangerous undertaking for the future. The central banks are being challenged.
Read
Commented by Stefan Feulner on August 4th, 2021 | 12:21 CEST
Evotec, Barsele Minerals, Nikola - When will the starting signal follow?
It has become quiet on the gold market. After the emerging fears of possible interest rate hikes due to rising inflation, the precious yellow metal remains in the range of around USD 1,800 per ounce. The price should be significantly higher due to the continued ultra-loose monetary policy of the central banks and the highs in government debt. Given that a slowdown in bond purchases or even larger interest rate hikes is hardly possible, a rise in the gold price can barely be avoided in the long term. The opportunity for an anticyclical entry is still given.
Read
Commented by Stefan Feulner on May 13th, 2021 | 08:55 CEST
Evotec, RYU Apparel, Adidas - This is just the beginning
Earnings season is in full swing. Yesterday, Bayer, Commerzbank and Varta, among others, presented good figures. Despite Corona restrictions and problems in the supply chain, sporting goods manufacturers were also able to deliver significant jumps in sales. Puma increased its sales by 26% in the first quarter. Along with the home office, sports at home or outdoors is the new trend. And this trend is likely to stay even after the pandemic. The potential for the sporting goods industry is enormous.
Read
Commented by Stefan Feulner on April 28th, 2021 | 07:04 CEST
CureVac, PsyBio, Evotec - Revolution in the billion-dollar market!
The anxiety and limitations associated with the coronavirus pose major challenges for people suffering from depression. Officially, around 350 million people worldwide live with depression, but the number of unreported cases is significantly higher. At the moment, the number one cause of the disease is only combated with antidepressants; there are hardly any alternative treatment methods without severe side effects. A completely new field is currently emerging that could completely eclipse existing drugs, with incredible potential for the young companies.
Read
Commented by Stefan Feulner on April 21st, 2021 | 09:30 CEST
Evotec, NSJ Gold, Infineon - The winners of inflation!
Inflation is coming in leaps and bounds. Although the Corona pandemic is not yet over, a strong economic recovery is emerging globally, driven by China and the United States. In the United States, price inflation was 2.6% in March and rising. Nevertheless, the Fed intends to continue its loose monetary policy, which was accelerated during the Corona Crisis, until at least 2023. In doing so, Fed Chairman Powell is overriding the basic principle of a central bank to take preventive action against inflation. There is a threat of monetary devaluation of historic proportions. We show how you can profit from this situation.
Read
Commented by Stefan Feulner on March 25th, 2021 | 08:19 CET
Evotec, PsyBio Therapeutics, MorphoSys - Milestone in Development!
About 350 million people worldwide live with depression. According to estimates by the World Health Organization (WHO), only one in four sufferers receives adequate treatment. With all its limitations, the Corona Crisis has caused the number of unreported cases to skyrocket exorbitantly, making depression the most significant cause of illness above all. Apart from the prescription of antidepressants, which usually have strong side effects, there are few alternative treatment methods. But now, young biotech companies are stepping up to revolutionize the field of "mental health."
Read
Commented by Carsten Mainitz on March 3rd, 2021 | 07:34 CET
Evotec, Cardiol Therapeutics, MorphoSys - Watch out: Great upside potential here in the short term
In the pandemic, investors have learned that small biotech companies, some still with a start-up character, can be worth billions overnight. BioNTech and CureVac are familiar names from the press. Both are linked by the Corona drug and the fact that they are headquartered in Germany. Two other German companies, Evotec and MorphoSys, have written a good growth story on the stock exchange in recent years: small becomes big! Small is also still the Canadian Cardiol Therapeutics. With the announced dual listing on the US technology exchange Nasdaq, a valuation boost could be imminent.
Read
Commented by Stefan Feulner on February 3rd, 2021 | 09:18 CET
Evotec, GS Holdings, TUI - Growth without end!
China's growth is almost uninterrupted. Experts predict that the Middle Kingdom will become the world's largest economy by 2028 at the latest. The fact that China has so far come out of the Corona Crisis in better shape means that the transition is likely to happen even sooner. The tiger economies such as Singapore, Hong Kong and Taiwan will also benefit. The upswing is giving rise to new business models with enormous growth potential for the coming years. We present the latest opportunities one by one.
Read